ClinicalTrials.govpublic full text
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
breast cancer, cardiac toxicity, male breast cancer, stage i breast cancer, stage ii breast cancer, stage iiia breast cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 861747
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.